FIELD: medicine. SUBSTANCE: method involves administering Roncoleukine in 2-4-fold application as drops into injured eye during 2 h at a dose of 100000 MU in 100 ml of physiological salt solution with 1 ml of 10% albumin solution added, and as intravenous infusions in dripping 400000 MU in 200 ml of physiological salt solution with 4-5 ml of 10% albumin solution added keeping the same rate of application. EFFECT: enhanced effectiveness of immunomodulation as local immunity repair; prevented disease recurrence.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OPHTHALMOHERPES TREATMENT ASSOCIATED WITH PROLONGED DEPRESSIONS | 2006 |
|
RU2327449C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
DRUG | 1996 |
|
RU2120294C1 |
METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
METHOD OF HERPETIC KERATITIS TREATMENT | 2007 |
|
RU2328252C1 |
METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 |
|
RU2421193C2 |
TREATMENT METHOD FOR CHRONIC CORNEA EROSIONS OF HERPETIC ETHIOLOGY | 2017 |
|
RU2653260C1 |
AGENT FOR TREATMENT OF VIRAL DISEASES CAUSED BY HERPES VIRUS | 1993 |
|
RU2068691C1 |
METHOD OF TREATMENT OF CENTRAL CORNEAL ULCERS OF BACTERIAL AND HERPETIC ETIOLOGY | 2018 |
|
RU2668713C1 |
Authors
Dates
2003-02-20—Published
2000-10-30—Filed